|
US5494660A
(en)
*
|
1985-06-18 |
1996-02-27 |
Emory University |
Method for inhibiting microbial binding to surfaces
|
|
US5466445A
(en)
*
|
1985-06-18 |
1995-11-14 |
Emory University |
Methods for reducing salmonella in chickens
|
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
|
US5451410A
(en)
*
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
|
US5800808A
(en)
*
|
1994-05-24 |
1998-09-01 |
Veda Research And Development Co., Ltd. |
Copolymer-1 improvements in compositions of copolymers
|
|
AU775214B2
(en)
*
|
1994-05-24 |
2004-07-22 |
Yeda Research And Development Co. Ltd. |
Copolymer-1 improvements in compositions of copolymers
|
|
AU741590B2
(en)
*
|
1994-05-24 |
2001-12-06 |
Yeda Research And Development Co. Ltd. |
Copolymer-1 improvements in compositions of copolymers
|
|
US6090958A
(en)
*
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5858964A
(en)
*
|
1995-04-14 |
1999-01-12 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
|
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
|
IL116559A
(en)
|
1995-11-17 |
2005-11-20 |
Yissum Res Dev Co |
Chimeric protein consisting of a bacterial toxin and a myelin basic protein sequence
|
|
IL126318A
(en)
|
1996-03-29 |
2004-09-27 |
Emisphere Tech Inc |
Compounds and compositions for delivering active agents and some novel carrier compounds
|
|
US6214791B1
(en)
*
|
1997-01-10 |
2001-04-10 |
Yeda Research And Development Co. Ltd. |
Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
|
|
US5804688A
(en)
*
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
|
US5863944A
(en)
*
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
US5962710A
(en)
*
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
|
ES2527760T3
(es)
*
|
1998-07-23 |
2015-01-29 |
Yeda Research And Development Co., Ltd. |
Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
|
|
IL140592A0
(en)
|
1998-07-23 |
2002-02-10 |
Harvard College |
Synthetic peptides and methods of use for autoimmune disease therapies
|
|
EP1098902A4
(en)
|
1998-07-23 |
2002-07-24 |
Yeda Res & Dev |
TREATMENT OF AUTOIMMUNE DISEASES BY COPOLYMER 1 AND SIMILAR COPOLYMERS AND PEPTIDES
|
|
US6800287B2
(en)
*
|
1998-09-25 |
2004-10-05 |
Yeda Research And Development Co., Ltd. |
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
|
|
US7083777B1
(en)
|
1999-04-02 |
2006-08-01 |
The Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
US6531130B1
(en)
*
|
1999-07-06 |
2003-03-11 |
The Board Of Trustees Of The Leland Stanford University |
Treatment of demyelinating autoimmune disease with ordered peptides
|
|
CA2397785C
(en)
*
|
2000-01-20 |
2009-01-13 |
Michal Eisenbach-Schwartz |
The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
|
|
ZA200206457B
(en)
*
|
2000-02-18 |
2003-08-13 |
Yeda Res & Dev |
Oral, nasal and pulmonary dosage formulations of copolymer 1.
|
|
US20020077278A1
(en)
*
|
2000-06-05 |
2002-06-20 |
Yong V. Wee |
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
|
|
CN100438906C
(zh)
*
|
2000-06-07 |
2008-12-03 |
耶达研究及发展有限公司 |
共聚物1和相关肽和多肽及其处理过的t细胞在保护cns细胞避免谷氨酸毒性中的用途
|
|
AU6887101A
(en)
*
|
2000-06-20 |
2002-01-02 |
Caprion Pharmaceuticals, Inc. |
Copolymers and methods of treating prion-related diseases
|
|
WO2002076503A1
(en)
*
|
2000-06-20 |
2002-10-03 |
Mayo Foundation For Medical Education And Research |
Treatment of central nervous system diseases by antibodies against glatiramer acetate
|
|
IL137460A0
(en)
*
|
2000-07-24 |
2001-07-24 |
Yeda Res & Dev |
Identifying antigen clusters for monitoring a global state of an immune system
|
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
SV2003000753A
(es)
|
2000-12-05 |
2003-06-16 |
Brigham & Womens Hospital |
Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
|
|
JP4369234B2
(ja)
*
|
2001-12-04 |
2009-11-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
グラチラマー・アセテートの強度の測定のための方法
|
|
NZ533356A
(en)
*
|
2001-12-06 |
2006-10-27 |
Yeda Res & Dev |
Vaccine and method for treatment of motor neurone diseases
|
|
EP1565486A2
(en)
*
|
2002-11-13 |
2005-08-24 |
Apotex Pharmachem Inc. |
Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine
|
|
WO2004091573A1
(en)
*
|
2003-03-04 |
2004-10-28 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis
|
|
AU2004227852B2
(en)
*
|
2003-03-31 |
2010-01-14 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic immunomodulators for the treatment of asthma and allergy
|
|
EP1680087A1
(en)
*
|
2003-10-31 |
2006-07-19 |
Teva Pharmaceutical Industries Limited |
Nanoparticles for drug delivery
|
|
JP5456235B2
(ja)
|
2003-11-12 |
2014-03-26 |
イエダ リサーチ アンド デベロップメント カンパニー リミテッド |
神経変性疾患を治療するためのワクチン及び方法
|
|
RU2006134701A
(ru)
*
|
2004-03-01 |
2008-04-10 |
Пептиммьюн |
Способы и композиции для лечения аутоиммунных заболеваний
|
|
US20050260770A1
(en)
*
|
2004-04-01 |
2005-11-24 |
Cohen Irun R |
Antigen array and diagnostic uses thereof
|
|
US20060194725A1
(en)
*
|
2004-05-07 |
2006-08-31 |
James Rasmussen |
Methods of treating disease with random copolymers
|
|
JP5495490B2
(ja)
|
2004-05-07 |
2014-05-21 |
アレス トレーディング エスエイ |
ランダム共重合体を用いる疾患の治療方法
|
|
US7655221B2
(en)
*
|
2004-05-07 |
2010-02-02 |
Peptimmune, Inc. |
Methods of treating disease with random copolymers
|
|
WO2005112911A2
(en)
*
|
2004-05-21 |
2005-12-01 |
The Regents Of The University Of California |
Compositions and methods for treating myelin deficiency disorders
|
|
NZ578727A
(en)
|
2004-06-25 |
2011-03-31 |
Brigham & Womens Hospital |
Proteosome compositions and methods for treating neurological disorders
|
|
ATE454396T1
(de)
*
|
2004-09-09 |
2010-01-15 |
Teva Pharma |
Verfahren zur herstellung von polypeptidmischungen unter anwendung von aufgereinigter bromwasserstoffsäure
|
|
PL1797109T3
(pl)
*
|
2004-09-09 |
2016-11-30 |
|
Mieszaniny polipeptydów, kompozycje zawierające je i procesy ich wytwarzania oraz ich zastosowania
|
|
CN101044188B
(zh)
*
|
2004-10-29 |
2010-08-04 |
桑多斯股份公司 |
制备格拉太咪尔的方法
|
|
NZ556156A
(en)
*
|
2005-02-02 |
2010-03-26 |
Teva Pharma |
Process for producing acetate salts of polypeptides using hydrogenolysis
|
|
WO2007022193A2
(en)
*
|
2005-08-15 |
2007-02-22 |
Wai Hong Chan |
Process for the preparation of copolymer-1
|
|
US8206726B2
(en)
|
2006-02-06 |
2012-06-26 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic polysaccharides for promotion of immune system maturation and health
|
|
CN101479607B
(zh)
|
2006-04-28 |
2013-10-02 |
莫门塔制药股份有限公司 |
评估肽混合物的方法
|
|
KR100831796B1
(ko)
*
|
2006-05-29 |
2008-05-28 |
엘지전자 주식회사 |
타임 쉬프트 기능을 내장한 영상표시기기 및 그 재생 방법
|
|
AU2007264682B2
(en)
|
2006-06-28 |
2012-09-06 |
Yeda Research & Development Co. Ltd |
Method of treatment of age-related macular degeneration
|
|
EP2134176A4
(en)
*
|
2007-03-30 |
2012-08-29 |
Brigham & Womens Hospital |
COMPOUNDS AND METHODS FOR ENHANCING MHC CLASS II THERAPIES
|
|
JP2010530975A
(ja)
*
|
2007-06-21 |
2010-09-16 |
モメンタ ファーマシューティカルズ インコーポレイテッド |
コポリマーアッセイ
|
|
EP2173766A1
(en)
*
|
2007-07-31 |
2010-04-14 |
Natco Pharma Limited |
Process for the preparation glatiramer acetate (copolymer-1)
|
|
US20090035816A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Scinopharm Taiwan Ltd. |
Process for the preparation of a polypeptide
|
|
EP2195008A1
(en)
|
2007-09-24 |
2010-06-16 |
Hadasit Medical Research Services & Development Ltd. |
Use of copolymer 1 for treatment of muscular dystrophy
|
|
ES2449865T5
(es)
|
2008-04-16 |
2022-11-18 |
Momenta Pharmaceuticals Inc |
Análisis de composiciones de copolímeros de aminoácidos
|
|
EP2326657B1
(en)
*
|
2008-08-07 |
2017-09-27 |
ScinoPharm Taiwan, Ltd. |
Synthesis of glatiramer acetate
|
|
AR074881A1
(es)
*
|
2008-12-24 |
2011-02-16 |
Synthon Bv |
Un proceso para purificar una mezcla de polimeros
|
|
RU2011144566A
(ru)
*
|
2009-04-03 |
2013-05-10 |
Момента Фармасьютикалз, Инк. |
Контроль сополимерных композиций
|
|
US9150609B2
(en)
|
2009-06-04 |
2015-10-06 |
Council Of Scientific & Industrial Research |
Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator
|
|
US8691790B2
(en)
*
|
2009-07-27 |
2014-04-08 |
James Layne Boucher |
Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
|
|
PT2630962T
(pt)
|
2009-08-20 |
2018-08-01 |
Yeda Res & Development Company Ltd |
Terapia de acetato de glatirâmero de baixa frequência
|
|
US8377885B2
(en)
|
2010-01-04 |
2013-02-19 |
Mapi Pharma Ltd. |
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
|
|
EP2398488B1
(en)
|
2010-01-04 |
2018-11-14 |
Mapi Pharma Limited |
Depot system comprising glatiramer acetate
|
|
USRE49251E1
(en)
|
2010-01-04 |
2022-10-18 |
Mapi Pharma Ltd. |
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
|
|
WO2011086470A1
(en)
|
2010-01-13 |
2011-07-21 |
Ramot At Tel-Aviv University Ltd |
Treatment of multiple sclerosis
|
|
US8709433B2
(en)
|
2010-10-11 |
2014-04-29 |
Teva Pharmaceutical Industries Ltd. |
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
|
|
WO2012054518A1
(en)
*
|
2010-10-18 |
2012-04-26 |
Lanco Biosciences, Inc. |
Delivery of copolymers by microinjection systems
|
|
WO2012123959A2
(en)
|
2011-02-14 |
2012-09-20 |
Usv Limited |
Copolymer-1, process for preparation and analytical methods thereof
|
|
EP2699317B1
(en)
*
|
2011-04-21 |
2016-08-10 |
Mapi Pharma Limited |
Random pentapolymer for treatment of autoimmune diseases
|
|
US20140348861A1
(en)
|
2011-05-05 |
2014-11-27 |
National Institute Of Immunology |
Synthetic peptides and random copolymers for the treatment of autoimmune disorders
|
|
WO2013009885A2
(en)
|
2011-07-11 |
2013-01-17 |
Momenta Pharmaceuticals, Inc. |
Evaluation of copolymer diethylamide
|
|
WO2013009864A1
(en)
|
2011-07-11 |
2013-01-17 |
Momenta Pharmaceuticals, Inc. |
Structure assessment of heterogeneous polypeptide mixtures
|
|
JP6273200B2
(ja)
|
2011-07-12 |
2018-01-31 |
ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド |
脂質含有ｐｓａ組成物、その単離の方法および使用の方法
|
|
US8575198B1
(en)
|
2011-09-07 |
2013-11-05 |
Momenta Pharmaceuticals, Inc. |
In-process control for the manufacture of glatiramer acetate
|
|
AU2012323345A1
(en)
|
2011-10-10 |
2014-05-22 |
Teva Pharmaceutical Industries Ltd. |
Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate
|
|
EP2642290A1
(en)
|
2012-03-19 |
2013-09-25 |
Synthon BV |
Glatiramer acetate human monocytic cell line-based potency assay
|
|
WO2013139728A1
(en)
|
2012-03-19 |
2013-09-26 |
Synthon Bv |
Glatiramer acetate human monocyte cell-based potency assay
|
|
WO2014058976A2
(en)
|
2012-10-10 |
2014-04-17 |
Teva Pharmaceutical Industries Ltd. |
Biomarkers predictive for clinical response for glatiramer acetate
|
|
WO2014060942A2
(en)
*
|
2012-10-20 |
2014-04-24 |
Mahesh Kandula |
Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases
|
|
RS53741B1
(en)
|
2013-03-08 |
2015-06-30 |
Teva Pharmaceutical Industries Ltd. |
Injectable Reusable Injection Device
|
|
EP2774640B1
(en)
|
2013-03-08 |
2014-12-31 |
Teva Pharmaceutical Industries, Ltd. |
Re-useable injector device for syringe
|
|
WO2014159685A2
(en)
|
2013-03-14 |
2014-10-02 |
Mylan Inc. |
Glatiramer acetate response biomarker mrna potency assay
|
|
WO2014173463A1
(en)
|
2013-04-26 |
2014-10-30 |
Synthon Bv |
Glatiramer acetate human monocytic cell line-based potency assay
|
|
CN103265624B
(zh)
*
|
2013-05-27 |
2015-04-22 |
成都圣诺生物制药有限公司 |
格拉替雷的制备方法
|
|
UY35790A
(es)
|
2013-10-21 |
2015-05-29 |
Teva Pharma |
Marcadores genéticos que predicen la respuesta al acetato de glatiramer
|
|
AU2014340010B2
(en)
|
2013-10-24 |
2021-05-27 |
Mylan Inc. |
Human T cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
|
|
WO2015101988A1
(en)
|
2013-12-31 |
2015-07-09 |
Yeda Research And Development Co. Ltd. |
Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
|
|
US10144778B2
(en)
|
2014-03-12 |
2018-12-04 |
Yeda Research And Development Co. Ltd |
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
|
|
EP3185882B1
(en)
|
2014-08-29 |
2019-10-09 |
Aarhus Universitet |
Positively charged co-polymers for use as antimicrobial agents
|
|
US9155775B1
(en)
|
2015-01-28 |
2015-10-13 |
Teva Pharmaceutical Industries, Ltd. |
Process for manufacturing glatiramer acetate product
|
|
CN107533058A
(zh)
|
2015-03-01 |
2018-01-02 |
免疫阵列有限公司 |
使用蛋白、肽和寡核苷酸抗原诊断系统性红斑狼疮
|
|
WO2017031431A1
(en)
|
2015-08-19 |
2017-02-23 |
President And Fellows Of Harvard College |
Lipidated psa compositions and methods
|
|
EP3147667B1
(en)
|
2015-09-24 |
2019-06-12 |
CHEMI S.p.A. |
Analysis of the molecular weight distribution of complex polypeptide mixtures
|
|
ES2707500T3
(es)
|
2015-11-23 |
2019-04-03 |
Chemi Spa |
Análisis mediante RP-HPLC de mezclas de polipéptidos complejos
|
|
EP3478300B1
(en)
|
2016-06-30 |
2022-08-24 |
Stem Cell Medicine Ltd. |
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
|
|
US11491181B2
(en)
|
2016-07-15 |
2022-11-08 |
President And Fellows Of Harvard College |
Glycolipid compositions and methods of use
|
|
CA3050086A1
(en)
|
2017-03-26 |
2018-10-04 |
Mapi Pharma Ltd. |
Glatiramer depot systems for treating progressive forms of multiple sclerosis
|
|
WO2018211486A1
(en)
|
2017-05-15 |
2018-11-22 |
Stem Cell Medicine Ltd. |
Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
|
|
EP3624816A4
(en)
|
2017-05-15 |
2021-02-24 |
Stem Cell Medicine Ltd. |
TREATMENT OF MULTIPLE SCLEROSIS WITH ADAPTIVE STEM CELLS
|
|
WO2019175869A1
(en)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Treatment of a heart disease
|
